nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Parkinson's disease—Clonazepam—epilepsy syndrome	0.218	0.554	CpDpCtD
Trihexyphenidyl—Parkinson's disease—Gabapentin—epilepsy syndrome	0.176	0.446	CpDpCtD
Trihexyphenidyl—CHRM3—epilepsy syndrome	0.151	0.371	CbGaD
Trihexyphenidyl—CHRM1—epilepsy syndrome	0.141	0.346	CbGaD
Trihexyphenidyl—CHRM2—epilepsy syndrome	0.115	0.283	CbGaD
Trihexyphenidyl—Biperiden—CHRNA2—epilepsy syndrome	0.00046	0.106	CrCbGaD
Trihexyphenidyl—Cycrimine—CHRM1—epilepsy syndrome	0.000326	0.0753	CrCbGaD
Trihexyphenidyl—CHRM4—head—epilepsy syndrome	0.000313	0.0605	CbGeAlD
Trihexyphenidyl—CHRM4—nervous system—epilepsy syndrome	0.000297	0.0574	CbGeAlD
Trihexyphenidyl—CHRM2—forebrain—epilepsy syndrome	0.000293	0.0567	CbGeAlD
Trihexyphenidyl—CHRM4—central nervous system—epilepsy syndrome	0.000286	0.0552	CbGeAlD
Trihexyphenidyl—Oxyphenonium—CHRM3—epilepsy syndrome	0.000278	0.0642	CrCbGaD
Trihexyphenidyl—CHRM2—telencephalon—epilepsy syndrome	0.00027	0.0521	CbGeAlD
Trihexyphenidyl—CHRM1—forebrain—epilepsy syndrome	0.000267	0.0516	CbGeAlD
Trihexyphenidyl—Oxyphenonium—CHRM1—epilepsy syndrome	0.000259	0.0598	CrCbGaD
Trihexyphenidyl—CHRM1—telencephalon—epilepsy syndrome	0.000245	0.0475	CbGeAlD
Trihexyphenidyl—CHRM5—head—epilepsy syndrome	0.000245	0.0473	CbGeAlD
Trihexyphenidyl—CHRM3—forebrain—epilepsy syndrome	0.000239	0.0462	CbGeAlD
Trihexyphenidyl—Oxyphencyclimine—CHRM3—epilepsy syndrome	0.000236	0.0546	CrCbGaD
Trihexyphenidyl—CHRM5—nervous system—epilepsy syndrome	0.000232	0.0448	CbGeAlD
Trihexyphenidyl—CHRM4—brain—epilepsy syndrome	0.000227	0.0438	CbGeAlD
Trihexyphenidyl—CHRM5—central nervous system—epilepsy syndrome	0.000223	0.0432	CbGeAlD
Trihexyphenidyl—Oxyphencyclimine—CHRM1—epilepsy syndrome	0.00022	0.0509	CrCbGaD
Trihexyphenidyl—CHRM3—telencephalon—epilepsy syndrome	0.00022	0.0425	CbGeAlD
Trihexyphenidyl—Biperiden—CHRM1—epilepsy syndrome	0.000201	0.0465	CrCbGaD
Trihexyphenidyl—Procyclidine—CHRM3—epilepsy syndrome	0.000201	0.0464	CrCbGaD
Trihexyphenidyl—Procyclidine—CHRM1—epilepsy syndrome	0.000187	0.0433	CrCbGaD
Trihexyphenidyl—Oxyphencyclimine—CHRM2—epilepsy syndrome	0.00018	0.0415	CrCbGaD
Trihexyphenidyl—CHRM5—brain—epilepsy syndrome	0.000177	0.0343	CbGeAlD
Trihexyphenidyl—Glycopyrrolate—CHRM3—epilepsy syndrome	0.00017	0.0392	CrCbGaD
Trihexyphenidyl—Oxybutynin—CHRM3—epilepsy syndrome	0.000168	0.0389	CrCbGaD
Trihexyphenidyl—CHRM2—head—epilepsy syndrome	0.000168	0.0325	CbGeAlD
Trihexyphenidyl—Biperiden—CHRM2—epilepsy syndrome	0.000165	0.038	CrCbGaD
Trihexyphenidyl—CHRM2—nervous system—epilepsy syndrome	0.000159	0.0308	CbGeAlD
Trihexyphenidyl—Glycopyrrolate—CHRM1—epilepsy syndrome	0.000158	0.0365	CrCbGaD
Trihexyphenidyl—Oxybutynin—CHRM1—epilepsy syndrome	0.000157	0.0363	CrCbGaD
Trihexyphenidyl—CHRM2—central nervous system—epilepsy syndrome	0.000153	0.0296	CbGeAlD
Trihexyphenidyl—Procyclidine—CHRM2—epilepsy syndrome	0.000153	0.0353	CrCbGaD
Trihexyphenidyl—CHRM1—head—epilepsy syndrome	0.000153	0.0295	CbGeAlD
Trihexyphenidyl—Somnolence—Propofol—epilepsy syndrome	0.000148	0.00125	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Acetazolamide—epilepsy syndrome	0.000147	0.00125	CcSEcCtD
Trihexyphenidyl—Dizziness—Rufinamide—epilepsy syndrome	0.000145	0.00123	CcSEcCtD
Trihexyphenidyl—Tachycardia—Diazepam—epilepsy syndrome	0.000145	0.00123	CcSEcCtD
Trihexyphenidyl—Confusional state—Felbamate—epilepsy syndrome	0.000145	0.00123	CcSEcCtD
Trihexyphenidyl—CHRM1—nervous system—epilepsy syndrome	0.000145	0.028	CbGeAlD
Trihexyphenidyl—Agitation—Carbamazepine—epilepsy syndrome	0.000145	0.00123	CcSEcCtD
Trihexyphenidyl—Somnolence—Midazolam—epilepsy syndrome	0.000144	0.00122	CcSEcCtD
Trihexyphenidyl—Asthenia—Clobazam—epilepsy syndrome	0.000144	0.00122	CcSEcCtD
Trihexyphenidyl—Vision blurred—Lamotrigine—epilepsy syndrome	0.000143	0.00122	CcSEcCtD
Trihexyphenidyl—Somnolence—Levetiracetam—epilepsy syndrome	0.000143	0.00121	CcSEcCtD
Trihexyphenidyl—Vomiting—Phenobarbital—epilepsy syndrome	0.000142	0.00121	CcSEcCtD
Trihexyphenidyl—Weight decreased—Pregabalin—epilepsy syndrome	0.000142	0.0012	CcSEcCtD
Trihexyphenidyl—Confusional state—Zonisamide—epilepsy syndrome	0.000142	0.0012	CcSEcCtD
Trihexyphenidyl—Rash—Phenobarbital—epilepsy syndrome	0.000141	0.0012	CcSEcCtD
Trihexyphenidyl—Dermatitis—Phenobarbital—epilepsy syndrome	0.000141	0.0012	CcSEcCtD
Trihexyphenidyl—Headache—Phenobarbital—epilepsy syndrome	0.00014	0.00119	CcSEcCtD
Trihexyphenidyl—Tachycardia—Felbamate—epilepsy syndrome	0.00014	0.00119	CcSEcCtD
Trihexyphenidyl—Agitation—Lamotrigine—epilepsy syndrome	0.00014	0.00119	CcSEcCtD
Trihexyphenidyl—Vomiting—Rufinamide—epilepsy syndrome	0.00014	0.00119	CcSEcCtD
Trihexyphenidyl—CHRM1—central nervous system—epilepsy syndrome	0.00014	0.027	CbGeAlD
Trihexyphenidyl—Constipation—Midazolam—epilepsy syndrome	0.000139	0.00118	CcSEcCtD
Trihexyphenidyl—Rash—Rufinamide—epilepsy syndrome	0.000139	0.00118	CcSEcCtD
Trihexyphenidyl—Dermatitis—Rufinamide—epilepsy syndrome	0.000139	0.00118	CcSEcCtD
Trihexyphenidyl—Hallucination—Valproic Acid—epilepsy syndrome	0.000138	0.00117	CcSEcCtD
Trihexyphenidyl—Headache—Rufinamide—epilepsy syndrome	0.000138	0.00117	CcSEcCtD
Trihexyphenidyl—Somnolence—Fosphenytoin—epilepsy syndrome	0.000138	0.00117	CcSEcCtD
Trihexyphenidyl—Tachycardia—Zonisamide—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—Constipation—Levetiracetam—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Topiramate—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—CHRM3—head—epilepsy syndrome	0.000137	0.0264	CbGeAlD
Trihexyphenidyl—Feeling abnormal—Propofol—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—Confusional state—Clonazepam—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—Dizziness—Lacosamide—epilepsy syndrome	0.000137	0.00116	CcSEcCtD
Trihexyphenidyl—Confusional state—Phenytoin—epilepsy syndrome	0.000136	0.00115	CcSEcCtD
Trihexyphenidyl—Diphenidol—CHRM3—epilepsy syndrome	0.000136	0.0313	CrCbGaD
Trihexyphenidyl—Confusional state—Oxcarbazepine—epilepsy syndrome	0.000135	0.00115	CcSEcCtD
Trihexyphenidyl—Somnolence—Vigabatrin—epilepsy syndrome	0.000134	0.00114	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Midazolam—epilepsy syndrome	0.000134	0.00114	CcSEcCtD
Trihexyphenidyl—Nausea—Phenobarbital—epilepsy syndrome	0.000133	0.00113	CcSEcCtD
Trihexyphenidyl—Dizziness—Clobazam—epilepsy syndrome	0.000133	0.00112	CcSEcCtD
Trihexyphenidyl—Tachycardia—Clonazepam—epilepsy syndrome	0.000132	0.00112	CcSEcCtD
Trihexyphenidyl—Constipation—Fosphenytoin—epilepsy syndrome	0.000132	0.00112	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000132	0.00112	CcSEcCtD
Trihexyphenidyl—Somnolence—Diazepam—epilepsy syndrome	0.000132	0.00112	CcSEcCtD
Trihexyphenidyl—Tachycardia—Phenytoin—epilepsy syndrome	0.000131	0.00112	CcSEcCtD
Trihexyphenidyl—Vomiting—Lacosamide—epilepsy syndrome	0.000131	0.00111	CcSEcCtD
Trihexyphenidyl—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000131	0.00111	CcSEcCtD
Trihexyphenidyl—Nausea—Rufinamide—epilepsy syndrome	0.000131	0.00111	CcSEcCtD
Trihexyphenidyl—Rash—Lacosamide—epilepsy syndrome	0.00013	0.0011	CcSEcCtD
Trihexyphenidyl—Weight decreased—Gabapentin—epilepsy syndrome	0.00013	0.0011	CcSEcCtD
Trihexyphenidyl—Dermatitis—Lacosamide—epilepsy syndrome	0.00013	0.0011	CcSEcCtD
Trihexyphenidyl—CHRM3—nervous system—epilepsy syndrome	0.00013	0.0251	CbGeAlD
Trihexyphenidyl—Confusional state—Carbamazepine—epilepsy syndrome	0.00013	0.0011	CcSEcCtD
Trihexyphenidyl—Headache—Lacosamide—epilepsy syndrome	0.000129	0.0011	CcSEcCtD
Trihexyphenidyl—Glycopyrrolate—CHRM2—epilepsy syndrome	0.000129	0.0298	CrCbGaD
Trihexyphenidyl—Constipation—Vigabatrin—epilepsy syndrome	0.000129	0.00109	CcSEcCtD
Trihexyphenidyl—Drowsiness—Gabapentin—epilepsy syndrome	0.000128	0.00109	CcSEcCtD
Trihexyphenidyl—Asthenia—Acetazolamide—epilepsy syndrome	0.000128	0.00109	CcSEcCtD
Trihexyphenidyl—Oxybutynin—CHRM2—epilepsy syndrome	0.000128	0.0296	CrCbGaD
Trihexyphenidyl—Somnolence—Felbamate—epilepsy syndrome	0.000128	0.00108	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000128	0.00108	CcSEcCtD
Trihexyphenidyl—Vomiting—Clobazam—epilepsy syndrome	0.000127	0.00108	CcSEcCtD
Trihexyphenidyl—Constipation—Diazepam—epilepsy syndrome	0.000127	0.00108	CcSEcCtD
Trihexyphenidyl—Diphenidol—CHRM1—epilepsy syndrome	0.000127	0.0292	CrCbGaD
Trihexyphenidyl—Rash—Clobazam—epilepsy syndrome	0.000126	0.00107	CcSEcCtD
Trihexyphenidyl—Dermatitis—Clobazam—epilepsy syndrome	0.000126	0.00107	CcSEcCtD
Trihexyphenidyl—Headache—Clobazam—epilepsy syndrome	0.000126	0.00107	CcSEcCtD
Trihexyphenidyl—Tachycardia—Carbamazepine—epilepsy syndrome	0.000125	0.00106	CcSEcCtD
Trihexyphenidyl—Confusional state—Lamotrigine—epilepsy syndrome	0.000125	0.00106	CcSEcCtD
Trihexyphenidyl—Somnolence—Zonisamide—epilepsy syndrome	0.000125	0.00106	CcSEcCtD
Trihexyphenidyl—Hallucination—Pregabalin—epilepsy syndrome	0.000125	0.00106	CcSEcCtD
Trihexyphenidyl—CHRM3—central nervous system—epilepsy syndrome	0.000125	0.0241	CbGeAlD
Trihexyphenidyl—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000124	0.00105	CcSEcCtD
Trihexyphenidyl—Constipation—Felbamate—epilepsy syndrome	0.000123	0.00104	CcSEcCtD
Trihexyphenidyl—Nausea—Lacosamide—epilepsy syndrome	0.000123	0.00104	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Diazepam—epilepsy syndrome	0.000122	0.00104	CcSEcCtD
Trihexyphenidyl—CHRM2—brain—epilepsy syndrome	0.000122	0.0235	CbGeAlD
Trihexyphenidyl—Tachycardia—Lamotrigine—epilepsy syndrome	0.000121	0.00103	CcSEcCtD
Trihexyphenidyl—Somnolence—Clonazepam—epilepsy syndrome	0.000121	0.00102	CcSEcCtD
Trihexyphenidyl—Constipation—Zonisamide—epilepsy syndrome	0.00012	0.00102	CcSEcCtD
Trihexyphenidyl—Somnolence—Phenytoin—epilepsy syndrome	0.00012	0.00102	CcSEcCtD
Trihexyphenidyl—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000119	0.00101	CcSEcCtD
Trihexyphenidyl—Nausea—Clobazam—epilepsy syndrome	0.000119	0.00101	CcSEcCtD
Trihexyphenidyl—Asthenia—Propofol—epilepsy syndrome	0.000119	0.00101	CcSEcCtD
Trihexyphenidyl—Tension—Valproic Acid—epilepsy syndrome	0.000119	0.00101	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Felbamate—epilepsy syndrome	0.000118	0.001	CcSEcCtD
Trihexyphenidyl—Dizziness—Acetazolamide—epilepsy syndrome	0.000118	0.001	CcSEcCtD
Trihexyphenidyl—Nervousness—Valproic Acid—epilepsy syndrome	0.000118	0.000997	CcSEcCtD
Trihexyphenidyl—Asthenia—Midazolam—epilepsy syndrome	0.000116	0.000988	CcSEcCtD
Trihexyphenidyl—Constipation—Clonazepam—epilepsy syndrome	0.000116	0.000984	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000116	0.000983	CcSEcCtD
Trihexyphenidyl—Constipation—Phenytoin—epilepsy syndrome	0.000115	0.000977	CcSEcCtD
Trihexyphenidyl—Asthenia—Levetiracetam—epilepsy syndrome	0.000115	0.000976	CcSEcCtD
Trihexyphenidyl—Hallucination—Gabapentin—epilepsy syndrome	0.000115	0.000972	CcSEcCtD
Trihexyphenidyl—Constipation—Oxcarbazepine—epilepsy syndrome	0.000115	0.000972	CcSEcCtD
Trihexyphenidyl—Somnolence—Carbamazepine—epilepsy syndrome	0.000114	0.00097	CcSEcCtD
Trihexyphenidyl—Vision blurred—Valproic Acid—epilepsy syndrome	0.000114	0.000967	CcSEcCtD
Trihexyphenidyl—Vomiting—Acetazolamide—epilepsy syndrome	0.000114	0.000964	CcSEcCtD
Trihexyphenidyl—Headache—Acetazolamide—epilepsy syndrome	0.000112	0.00095	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000112	0.000948	CcSEcCtD
Trihexyphenidyl—Agitation—Valproic Acid—epilepsy syndrome	0.000111	0.000943	CcSEcCtD
Trihexyphenidyl—Asthenia—Fosphenytoin—epilepsy syndrome	0.000111	0.000942	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000111	0.000941	CcSEcCtD
Trihexyphenidyl—CHRM1—brain—epilepsy syndrome	0.000111	0.0214	CbGeAlD
Trihexyphenidyl—Somnolence—Lamotrigine—epilepsy syndrome	0.00011	0.000937	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.00011	0.000937	CcSEcCtD
Trihexyphenidyl—Constipation—Carbamazepine—epilepsy syndrome	0.00011	0.000933	CcSEcCtD
Trihexyphenidyl—Dizziness—Propofol—epilepsy syndrome	0.00011	0.000931	CcSEcCtD
Trihexyphenidyl—Weight decreased—Topiramate—epilepsy syndrome	0.00011	0.000929	CcSEcCtD
Trihexyphenidyl—Asthenia—Vigabatrin—epilepsy syndrome	0.000108	0.000918	CcSEcCtD
Trihexyphenidyl—Dizziness—Midazolam—epilepsy syndrome	0.000107	0.000911	CcSEcCtD
Trihexyphenidyl—Tension—Pregabalin—epilepsy syndrome	0.000107	0.00091	CcSEcCtD
Trihexyphenidyl—Asthenia—Diazepam—epilepsy syndrome	0.000107	0.000904	CcSEcCtD
Trihexyphenidyl—Constipation—Lamotrigine—epilepsy syndrome	0.000106	0.000901	CcSEcCtD
Trihexyphenidyl—Nervousness—Pregabalin—epilepsy syndrome	0.000106	0.000901	CcSEcCtD
Trihexyphenidyl—Nausea—Acetazolamide—epilepsy syndrome	0.000106	0.0009	CcSEcCtD
Trihexyphenidyl—Dizziness—Levetiracetam—epilepsy syndrome	0.000106	0.000899	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000106	0.000899	CcSEcCtD
Trihexyphenidyl—Vomiting—Propofol—epilepsy syndrome	0.000106	0.000895	CcSEcCtD
Trihexyphenidyl—Rash—Propofol—epilepsy syndrome	0.000105	0.000888	CcSEcCtD
Trihexyphenidyl—Dermatitis—Propofol—epilepsy syndrome	0.000105	0.000887	CcSEcCtD
Trihexyphenidyl—Headache—Propofol—epilepsy syndrome	0.000104	0.000882	CcSEcCtD
Trihexyphenidyl—Diphenidol—CHRM2—epilepsy syndrome	0.000103	0.0239	CrCbGaD
Trihexyphenidyl—Vomiting—Midazolam—epilepsy syndrome	0.000103	0.000876	CcSEcCtD
Trihexyphenidyl—Asthenia—Felbamate—epilepsy syndrome	0.000103	0.000875	CcSEcCtD
Trihexyphenidyl—Vision blurred—Pregabalin—epilepsy syndrome	0.000103	0.000874	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000102	0.000869	CcSEcCtD
Trihexyphenidyl—Rash—Midazolam—epilepsy syndrome	0.000102	0.000868	CcSEcCtD
Trihexyphenidyl—Dizziness—Fosphenytoin—epilepsy syndrome	0.000102	0.000868	CcSEcCtD
Trihexyphenidyl—Dermatitis—Midazolam—epilepsy syndrome	0.000102	0.000868	CcSEcCtD
Trihexyphenidyl—Vomiting—Levetiracetam—epilepsy syndrome	0.000102	0.000865	CcSEcCtD
Trihexyphenidyl—Headache—Midazolam—epilepsy syndrome	0.000102	0.000863	CcSEcCtD
Trihexyphenidyl—Rash—Levetiracetam—epilepsy syndrome	0.000101	0.000858	CcSEcCtD
Trihexyphenidyl—Dermatitis—Levetiracetam—epilepsy syndrome	0.000101	0.000857	CcSEcCtD
Trihexyphenidyl—Asthenia—Zonisamide—epilepsy syndrome	0.000101	0.000856	CcSEcCtD
Trihexyphenidyl—Agitation—Pregabalin—epilepsy syndrome	0.000101	0.000853	CcSEcCtD
Trihexyphenidyl—Headache—Levetiracetam—epilepsy syndrome	0.0001	0.000852	CcSEcCtD
Trihexyphenidyl—Dizziness—Vigabatrin—epilepsy syndrome	9.98e-05	0.000846	CcSEcCtD
Trihexyphenidyl—Confusional state—Valproic Acid—epilepsy syndrome	9.96e-05	0.000845	CcSEcCtD
Trihexyphenidyl—CHRM3—brain—epilepsy syndrome	9.91e-05	0.0192	CbGeAlD
Trihexyphenidyl—Nausea—Propofol—epilepsy syndrome	9.86e-05	0.000836	CcSEcCtD
Trihexyphenidyl—Tension—Gabapentin—epilepsy syndrome	9.84e-05	0.000835	CcSEcCtD
Trihexyphenidyl—Vomiting—Fosphenytoin—epilepsy syndrome	9.84e-05	0.000835	CcSEcCtD
Trihexyphenidyl—Dizziness—Diazepam—epilepsy syndrome	9.82e-05	0.000833	CcSEcCtD
Trihexyphenidyl—Rash—Fosphenytoin—epilepsy syndrome	9.76e-05	0.000828	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fosphenytoin—epilepsy syndrome	9.75e-05	0.000827	CcSEcCtD
Trihexyphenidyl—Nervousness—Gabapentin—epilepsy syndrome	9.74e-05	0.000826	CcSEcCtD
Trihexyphenidyl—Asthenia—Clonazepam—epilepsy syndrome	9.73e-05	0.000825	CcSEcCtD
Trihexyphenidyl—Headache—Fosphenytoin—epilepsy syndrome	9.69e-05	0.000822	CcSEcCtD
Trihexyphenidyl—Asthenia—Phenytoin—epilepsy syndrome	9.66e-05	0.00082	CcSEcCtD
Trihexyphenidyl—Nausea—Midazolam—epilepsy syndrome	9.64e-05	0.000818	CcSEcCtD
Trihexyphenidyl—Hallucination—Topiramate—epilepsy syndrome	9.64e-05	0.000818	CcSEcCtD
Trihexyphenidyl—Tachycardia—Valproic Acid—epilepsy syndrome	9.64e-05	0.000817	CcSEcCtD
Trihexyphenidyl—Asthenia—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000815	CcSEcCtD
Trihexyphenidyl—Vomiting—Vigabatrin—epilepsy syndrome	9.59e-05	0.000814	CcSEcCtD
Trihexyphenidyl—Nausea—Levetiracetam—epilepsy syndrome	9.52e-05	0.000808	CcSEcCtD
Trihexyphenidyl—Rash—Vigabatrin—epilepsy syndrome	9.51e-05	0.000807	CcSEcCtD
Trihexyphenidyl—Dizziness—Felbamate—epilepsy syndrome	9.5e-05	0.000806	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vigabatrin—epilepsy syndrome	9.5e-05	0.000806	CcSEcCtD
Trihexyphenidyl—Vision blurred—Gabapentin—epilepsy syndrome	9.45e-05	0.000802	CcSEcCtD
Trihexyphenidyl—Headache—Vigabatrin—epilepsy syndrome	9.45e-05	0.000802	CcSEcCtD
Trihexyphenidyl—Vomiting—Diazepam—epilepsy syndrome	9.44e-05	0.000801	CcSEcCtD
Trihexyphenidyl—Rash—Diazepam—epilepsy syndrome	9.36e-05	0.000794	CcSEcCtD
Trihexyphenidyl—Dermatitis—Diazepam—epilepsy syndrome	9.35e-05	0.000794	CcSEcCtD
Trihexyphenidyl—Dizziness—Zonisamide—epilepsy syndrome	9.3e-05	0.000789	CcSEcCtD
Trihexyphenidyl—Headache—Diazepam—epilepsy syndrome	9.3e-05	0.000789	CcSEcCtD
Trihexyphenidyl—Asthenia—Carbamazepine—epilepsy syndrome	9.22e-05	0.000782	CcSEcCtD
Trihexyphenidyl—Agitation—Gabapentin—epilepsy syndrome	9.22e-05	0.000782	CcSEcCtD
Trihexyphenidyl—Nausea—Fosphenytoin—epilepsy syndrome	9.19e-05	0.00078	CcSEcCtD
Trihexyphenidyl—Vomiting—Felbamate—epilepsy syndrome	9.14e-05	0.000775	CcSEcCtD
Trihexyphenidyl—Rash—Felbamate—epilepsy syndrome	9.06e-05	0.000769	CcSEcCtD
Trihexyphenidyl—Dermatitis—Felbamate—epilepsy syndrome	9.05e-05	0.000768	CcSEcCtD
Trihexyphenidyl—Headache—Felbamate—epilepsy syndrome	9e-05	0.000764	CcSEcCtD
Trihexyphenidyl—Confusional state—Pregabalin—epilepsy syndrome	9e-05	0.000763	CcSEcCtD
Trihexyphenidyl—Dizziness—Clonazepam—epilepsy syndrome	8.97e-05	0.000761	CcSEcCtD
Trihexyphenidyl—Nausea—Vigabatrin—epilepsy syndrome	8.96e-05	0.00076	CcSEcCtD
Trihexyphenidyl—Vomiting—Zonisamide—epilepsy syndrome	8.95e-05	0.000759	CcSEcCtD
Trihexyphenidyl—Asthenia—Lamotrigine—epilepsy syndrome	8.91e-05	0.000756	CcSEcCtD
Trihexyphenidyl—Dizziness—Phenytoin—epilepsy syndrome	8.91e-05	0.000756	CcSEcCtD
Trihexyphenidyl—Rash—Zonisamide—epilepsy syndrome	8.87e-05	0.000752	CcSEcCtD
Trihexyphenidyl—Dermatitis—Zonisamide—epilepsy syndrome	8.86e-05	0.000752	CcSEcCtD
Trihexyphenidyl—Dizziness—Oxcarbazepine—epilepsy syndrome	8.86e-05	0.000752	CcSEcCtD
Trihexyphenidyl—Nausea—Diazepam—epilepsy syndrome	8.82e-05	0.000748	CcSEcCtD
Trihexyphenidyl—Headache—Zonisamide—epilepsy syndrome	8.81e-05	0.000748	CcSEcCtD
Trihexyphenidyl—Somnolence—Valproic Acid—epilepsy syndrome	8.78e-05	0.000745	CcSEcCtD
Trihexyphenidyl—Tachycardia—Pregabalin—epilepsy syndrome	8.71e-05	0.000739	CcSEcCtD
Trihexyphenidyl—Vomiting—Clonazepam—epilepsy syndrome	8.62e-05	0.000731	CcSEcCtD
Trihexyphenidyl—Vomiting—Phenytoin—epilepsy syndrome	8.56e-05	0.000726	CcSEcCtD
Trihexyphenidyl—Rash—Clonazepam—epilepsy syndrome	8.55e-05	0.000725	CcSEcCtD
Trihexyphenidyl—Dermatitis—Clonazepam—epilepsy syndrome	8.54e-05	0.000725	CcSEcCtD
Trihexyphenidyl—Nausea—Felbamate—epilepsy syndrome	8.54e-05	0.000724	CcSEcCtD
Trihexyphenidyl—Vomiting—Oxcarbazepine—epilepsy syndrome	8.52e-05	0.000723	CcSEcCtD
Trihexyphenidyl—Dizziness—Carbamazepine—epilepsy syndrome	8.5e-05	0.000721	CcSEcCtD
Trihexyphenidyl—Headache—Clonazepam—epilepsy syndrome	8.49e-05	0.000721	CcSEcCtD
Trihexyphenidyl—Rash—Phenytoin—epilepsy syndrome	8.49e-05	0.00072	CcSEcCtD
Trihexyphenidyl—Dermatitis—Phenytoin—epilepsy syndrome	8.48e-05	0.00072	CcSEcCtD
Trihexyphenidyl—Rash—Oxcarbazepine—epilepsy syndrome	8.45e-05	0.000717	CcSEcCtD
Trihexyphenidyl—Constipation—Valproic Acid—epilepsy syndrome	8.44e-05	0.000716	CcSEcCtD
Trihexyphenidyl—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.44e-05	0.000716	CcSEcCtD
Trihexyphenidyl—Headache—Phenytoin—epilepsy syndrome	8.44e-05	0.000716	CcSEcCtD
Trihexyphenidyl—Headache—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000712	CcSEcCtD
Trihexyphenidyl—Nausea—Zonisamide—epilepsy syndrome	8.36e-05	0.000709	CcSEcCtD
Trihexyphenidyl—Tension—Topiramate—epilepsy syndrome	8.28e-05	0.000702	CcSEcCtD
Trihexyphenidyl—Confusional state—Gabapentin—epilepsy syndrome	8.25e-05	0.0007	CcSEcCtD
Trihexyphenidyl—Dizziness—Lamotrigine—epilepsy syndrome	8.22e-05	0.000697	CcSEcCtD
Trihexyphenidyl—Nervousness—Topiramate—epilepsy syndrome	8.2e-05	0.000695	CcSEcCtD
Trihexyphenidyl—Vomiting—Carbamazepine—epilepsy syndrome	8.17e-05	0.000693	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.14e-05	0.00069	CcSEcCtD
Trihexyphenidyl—Rash—Carbamazepine—epilepsy syndrome	8.11e-05	0.000688	CcSEcCtD
Trihexyphenidyl—Dermatitis—Carbamazepine—epilepsy syndrome	8.1e-05	0.000687	CcSEcCtD
Trihexyphenidyl—Nausea—Clonazepam—epilepsy syndrome	8.05e-05	0.000683	CcSEcCtD
Trihexyphenidyl—Headache—Carbamazepine—epilepsy syndrome	8.05e-05	0.000683	CcSEcCtD
Trihexyphenidyl—Nausea—Phenytoin—epilepsy syndrome	8e-05	0.000679	CcSEcCtD
Trihexyphenidyl—Tachycardia—Gabapentin—epilepsy syndrome	7.99e-05	0.000678	CcSEcCtD
Trihexyphenidyl—Nausea—Oxcarbazepine—epilepsy syndrome	7.96e-05	0.000675	CcSEcCtD
Trihexyphenidyl—Vision blurred—Topiramate—epilepsy syndrome	7.95e-05	0.000675	CcSEcCtD
Trihexyphenidyl—Somnolence—Pregabalin—epilepsy syndrome	7.94e-05	0.000673	CcSEcCtD
Trihexyphenidyl—Vomiting—Lamotrigine—epilepsy syndrome	7.9e-05	0.00067	CcSEcCtD
Trihexyphenidyl—Rash—Lamotrigine—epilepsy syndrome	7.83e-05	0.000665	CcSEcCtD
Trihexyphenidyl—Dermatitis—Lamotrigine—epilepsy syndrome	7.83e-05	0.000664	CcSEcCtD
Trihexyphenidyl—Headache—Lamotrigine—epilepsy syndrome	7.78e-05	0.00066	CcSEcCtD
Trihexyphenidyl—Agitation—Topiramate—epilepsy syndrome	7.75e-05	0.000658	CcSEcCtD
Trihexyphenidyl—Nausea—Carbamazepine—epilepsy syndrome	7.64e-05	0.000648	CcSEcCtD
Trihexyphenidyl—Constipation—Pregabalin—epilepsy syndrome	7.63e-05	0.000648	CcSEcCtD
Trihexyphenidyl—Biperiden—CYP2D6—epilepsy syndrome	7.53e-05	0.0174	CrCbGaD
Trihexyphenidyl—Nausea—Lamotrigine—epilepsy syndrome	7.38e-05	0.000626	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Pregabalin—epilepsy syndrome	7.36e-05	0.000624	CcSEcCtD
Trihexyphenidyl—Somnolence—Gabapentin—epilepsy syndrome	7.28e-05	0.000617	CcSEcCtD
Trihexyphenidyl—Asthenia—Valproic Acid—epilepsy syndrome	7.08e-05	0.000601	CcSEcCtD
Trihexyphenidyl—Constipation—Gabapentin—epilepsy syndrome	7e-05	0.000594	CcSEcCtD
Trihexyphenidyl—Confusional state—Topiramate—epilepsy syndrome	6.94e-05	0.000589	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Gabapentin—epilepsy syndrome	6.75e-05	0.000572	CcSEcCtD
Trihexyphenidyl—Tachycardia—Topiramate—epilepsy syndrome	6.72e-05	0.00057	CcSEcCtD
Trihexyphenidyl—Dizziness—Valproic Acid—epilepsy syndrome	6.53e-05	0.000554	CcSEcCtD
Trihexyphenidyl—Asthenia—Pregabalin—epilepsy syndrome	6.4e-05	0.000543	CcSEcCtD
Trihexyphenidyl—Vomiting—Valproic Acid—epilepsy syndrome	6.28e-05	0.000533	CcSEcCtD
Trihexyphenidyl—Rash—Valproic Acid—epilepsy syndrome	6.23e-05	0.000528	CcSEcCtD
Trihexyphenidyl—Dermatitis—Valproic Acid—epilepsy syndrome	6.22e-05	0.000528	CcSEcCtD
Trihexyphenidyl—Headache—Valproic Acid—epilepsy syndrome	6.19e-05	0.000525	CcSEcCtD
Trihexyphenidyl—Somnolence—Topiramate—epilepsy syndrome	6.12e-05	0.000519	CcSEcCtD
Trihexyphenidyl—Dizziness—Pregabalin—epilepsy syndrome	5.9e-05	0.000501	CcSEcCtD
Trihexyphenidyl—Constipation—Topiramate—epilepsy syndrome	5.89e-05	0.0005	CcSEcCtD
Trihexyphenidyl—Asthenia—Gabapentin—epilepsy syndrome	5.87e-05	0.000498	CcSEcCtD
Trihexyphenidyl—Nausea—Valproic Acid—epilepsy syndrome	5.86e-05	0.000497	CcSEcCtD
Trihexyphenidyl—Oxybutynin—CYP2D6—epilepsy syndrome	5.86e-05	0.0135	CrCbGaD
Trihexyphenidyl—Vomiting—Pregabalin—epilepsy syndrome	5.68e-05	0.000481	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Topiramate—epilepsy syndrome	5.67e-05	0.000481	CcSEcCtD
Trihexyphenidyl—Rash—Pregabalin—epilepsy syndrome	5.63e-05	0.000477	CcSEcCtD
Trihexyphenidyl—Dermatitis—Pregabalin—epilepsy syndrome	5.62e-05	0.000477	CcSEcCtD
Trihexyphenidyl—Headache—Pregabalin—epilepsy syndrome	5.59e-05	0.000474	CcSEcCtD
Trihexyphenidyl—Dizziness—Gabapentin—epilepsy syndrome	5.41e-05	0.000459	CcSEcCtD
Trihexyphenidyl—Biperiden—ABCB1—epilepsy syndrome	5.38e-05	0.0124	CrCbGaD
Trihexyphenidyl—Nausea—Pregabalin—epilepsy syndrome	5.3e-05	0.00045	CcSEcCtD
Trihexyphenidyl—Vomiting—Gabapentin—epilepsy syndrome	5.2e-05	0.000441	CcSEcCtD
Trihexyphenidyl—Rash—Gabapentin—epilepsy syndrome	5.16e-05	0.000438	CcSEcCtD
Trihexyphenidyl—Dermatitis—Gabapentin—epilepsy syndrome	5.16e-05	0.000437	CcSEcCtD
Trihexyphenidyl—Headache—Gabapentin—epilepsy syndrome	5.13e-05	0.000435	CcSEcCtD
Trihexyphenidyl—Asthenia—Topiramate—epilepsy syndrome	4.94e-05	0.000419	CcSEcCtD
Trihexyphenidyl—Nausea—Gabapentin—epilepsy syndrome	4.86e-05	0.000412	CcSEcCtD
Trihexyphenidyl—Dizziness—Topiramate—epilepsy syndrome	4.55e-05	0.000386	CcSEcCtD
Trihexyphenidyl—Vomiting—Topiramate—epilepsy syndrome	4.38e-05	0.000371	CcSEcCtD
Trihexyphenidyl—Rash—Topiramate—epilepsy syndrome	4.34e-05	0.000368	CcSEcCtD
Trihexyphenidyl—Dermatitis—Topiramate—epilepsy syndrome	4.34e-05	0.000368	CcSEcCtD
Trihexyphenidyl—Headache—Topiramate—epilepsy syndrome	4.31e-05	0.000366	CcSEcCtD
Trihexyphenidyl—Nausea—Topiramate—epilepsy syndrome	4.09e-05	0.000347	CcSEcCtD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	5.58e-06	7.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	5.56e-06	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	5.56e-06	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	5.56e-06	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	5.56e-06	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	5.56e-06	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	5.56e-06	7.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PLCB1—epilepsy syndrome	5.53e-06	7.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TH—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	5.51e-06	7.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	5.5e-06	7.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	5.49e-06	7.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	5.43e-06	7.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AVP—epilepsy syndrome	5.43e-06	7.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	5.39e-06	7.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	5.37e-06	7.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HES1—epilepsy syndrome	5.36e-06	7.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.32e-06	7.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FYN—epilepsy syndrome	5.22e-06	7.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.2e-06	7.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—H2AFX—epilepsy syndrome	5.2e-06	7.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.19e-06	7.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MEF2C—epilepsy syndrome	5.19e-06	7.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.19e-06	7.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.18e-06	7.29e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	5.17e-06	7.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	5.17e-06	7.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	5.14e-06	7.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.13e-06	7.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	5.12e-06	7.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	5.12e-06	7.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.11e-06	7.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	5.1e-06	7.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.05e-06	7.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.05e-06	7.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.05e-06	7.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	5.05e-06	7.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	5.03e-06	7.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	5.03e-06	7.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SST—epilepsy syndrome	5.03e-06	7.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—YWHAZ—epilepsy syndrome	5.01e-06	7.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5e-06	7.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	4.99e-06	7.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	4.99e-06	7.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	4.98e-06	7.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	4.98e-06	7.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SST—epilepsy syndrome	4.98e-06	7.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	4.98e-06	7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	4.97e-06	6.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	4.96e-06	6.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.94e-06	6.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	4.94e-06	6.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	4.92e-06	6.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	4.92e-06	6.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	4.9e-06	6.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.87e-06	6.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.85e-06	6.83e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	4.82e-06	6.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	4.8e-06	6.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	4.75e-06	6.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.74e-06	6.67e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.74e-06	6.67e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.74e-06	6.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	4.73e-06	6.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	4.73e-06	6.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.72e-06	6.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.72e-06	6.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	4.72e-06	6.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.71e-06	6.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.7e-06	6.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	4.69e-06	6.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.68e-06	6.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.68e-06	6.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.68e-06	6.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.66e-06	6.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.66e-06	6.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.66e-06	6.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.64e-06	6.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	4.64e-06	6.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	4.64e-06	6.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.64e-06	6.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	4.63e-06	6.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	4.62e-06	6.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—HMOX1—epilepsy syndrome	4.6e-06	6.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.6e-06	6.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.6e-06	6.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.58e-06	6.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.54e-06	6.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAT—epilepsy syndrome	4.54e-06	6.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.53e-06	6.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	4.52e-06	6.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.49e-06	6.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	4.48e-06	6.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	4.48e-06	6.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.42e-06	6.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.41e-06	6.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.4e-06	6.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	4.39e-06	6.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.35e-06	6.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.33e-06	6.09e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.32e-06	6.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.3e-06	6.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	4.3e-06	6.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	4.29e-06	6.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.29e-06	6.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	4.29e-06	6.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.27e-06	6.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.25e-06	5.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.23e-06	5.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.22e-06	5.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.21e-06	5.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	4.2e-06	5.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.2e-06	5.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.17e-06	5.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.16e-06	5.84e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	4.14e-06	5.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	4.12e-06	5.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	4.12e-06	5.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.11e-06	5.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4e-06	5.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	3.99e-06	5.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	3.96e-06	5.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.96e-06	5.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.95e-06	5.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.95e-06	5.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	3.95e-06	5.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	3.95e-06	5.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	3.94e-06	5.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.91e-06	5.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.9e-06	5.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.82e-06	5.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.81e-06	5.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.78e-06	5.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	3.77e-06	5.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	3.69e-06	5.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.62e-06	5.09e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	3.61e-06	5.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.61e-06	5.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AGT—epilepsy syndrome	3.6e-06	5.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.57e-06	5.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.53e-06	4.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—epilepsy syndrome	3.53e-06	4.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.52e-06	4.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.51e-06	4.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.5e-06	4.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.5e-06	4.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.49e-06	4.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.49e-06	4.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.47e-06	4.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.46e-06	4.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.45e-06	4.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.38e-06	4.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.37e-06	4.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.34e-06	4.7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.34e-06	4.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	3.33e-06	4.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.33e-06	4.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.3e-06	4.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.25e-06	4.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.24e-06	4.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.21e-06	4.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	3.19e-06	4.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.18e-06	4.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.17e-06	4.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.14e-06	4.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	3.09e-06	4.35e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	3.03e-06	4.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—epilepsy syndrome	3.03e-06	4.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.02e-06	4.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.02e-06	4.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.01e-06	4.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.01e-06	4.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.98e-06	4.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.98e-06	4.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	2.96e-06	4.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.96e-06	4.16e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.95e-06	4.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.92e-06	4.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.91e-06	4.09e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.9e-06	4.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.89e-06	4.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.86e-06	4.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	2.82e-06	3.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	2.79e-06	3.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.79e-06	3.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.78e-06	3.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.78e-06	3.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.77e-06	3.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—epilepsy syndrome	2.76e-06	3.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.75e-06	3.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.74e-06	3.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	2.71e-06	3.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.7e-06	3.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.67e-06	3.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	2.64e-06	3.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.6e-06	3.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.56e-06	3.6e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.54e-06	3.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.53e-06	3.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.53e-06	3.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.51e-06	3.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-06	3.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.48e-06	3.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.45e-06	3.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.45e-06	3.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.43e-06	3.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.42e-06	3.4e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.37e-06	3.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.33e-06	3.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.27e-06	3.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-06	3.16e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.24e-06	3.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.22e-06	3.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.09e-06	2.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.08e-06	2.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.06e-06	2.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-06	2.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.04e-06	2.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.02e-06	2.84e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-06	2.67e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.89e-06	2.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.88e-06	2.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.88e-06	2.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.87e-06	2.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.86e-06	2.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.83e-06	2.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.82e-06	2.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.8e-06	2.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-06	2.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.77e-06	2.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.76e-06	2.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.72e-06	2.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.72e-06	2.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.7e-06	2.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.64e-06	2.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.63e-06	2.3e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.62e-06	2.28e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-06	2.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.59e-06	2.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.58e-06	2.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.51e-06	2.13e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-06	2.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.21e-06	1.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	1.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	1.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-06	1.41e-05	CbGpPWpGaD
